Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Rehab program shows promise for scleroderma Patients' daily life

NCT ID NCT00318188

First seen Jan 25, 2026 · Last updated Jun 22, 2026 · Updated 20 times

Summary

This study tested whether a personalized rehabilitation program could improve quality of life for people with systemic sclerosis, a disease that causes skin and joint stiffness. 220 adults with the condition were randomly assigned to either the rehab program or usual care. The program focused on exercises and activities to reduce disability and improve daily function.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SYSTEMIC SCLERODERMA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Locations

  • Reeducation and readaptation Department

    Paris, 75679, France

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance

personalized standardized rehabilitation program

What this could lead to

If successful, this could offer a non-drug way to improve daily function and quality of life for people with systemic sclerosis.

What could go wrong

This is a completed trial, but rehabilitation effects can vary widely. The program may not work for everyone, and results depend on patient adherence.

Conditions

The condition(s) this trial relates to.

diffuse scleroderma systemic sclerosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.